Extensive stage small cell lung cancer: determining suitability for outpatient management of febrile neutropenia

Semin Oncol. 1996 Apr;23(2):xv-xxii; discussion xxii.

Authors

J S Rapp¹, M C Perry, R M Rotche

Affiliation

¹ Division of Infectious Diseases, Thomas Jefferson University, Philadelphia, PA, USA.

PMID: 8623054

No abstract available

Publication types

Case Reports

MeSH terms

Adrenal Gland Neoplasms / secondary
Ambulatory Care*
Anti-Bacterial Agents / therapeutic use
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects
Antineoplastic Agents, Phytogenic / administration & dosage
Antineoplastic Agents, Phytogenic / adverse effects
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Small Cell / drug therapy*
Carcinoma, Small Cell / secondary
Cisplatin / administration & dosage
Cisplatin / adverse effects
Decision Making
Etoposide / administration & dosage
Etoposide / adverse effects
Female
Fever / therapy*
Hospitalization
Humans
Liver Neoplasms / secondary
Lung Neoplasms / drug therapy*
Middle Aged
Neutropenia / therapy*

Substances

Anti-Bacterial Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Etoposide
Cisplatin